| Product Code: ETC7660557 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel`s rapid acting insulin import market saw significant contributions from top exporting countries such as Switzerland, USA, Germany, China, and Belgium in 2024. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market with dominant players. Despite the overall negative compound annual growth rate (CAGR) from 2020 to 2024, there was a notable growth spurt in 2024 with a positive rate of 8.63%. This suggests a potential shift or development within the market that could be worth monitoring for future trends and opportunities.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Rapid Acting Insulin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Rapid Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Rapid Acting Insulin Market - Industry Life Cycle |
3.4 Israel Rapid Acting Insulin Market - Porter's Five Forces |
3.5 Israel Rapid Acting Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Rapid Acting Insulin Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Rapid Acting Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Rapid Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Israel |
4.2.2 Growing adoption of rapid acting insulin due to its effectiveness |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 High cost associated with rapid acting insulin |
4.3.2 Stringent regulatory requirements for insulin products in Israel |
5 Israel Rapid Acting Insulin Market Trends |
6 Israel Rapid Acting Insulin Market, By Types |
6.1 Israel Rapid Acting Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Rapid Acting Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Rapid Acting Insulin Market Revenues & Volume, By Lispro Insulin, 2021- 2031F |
6.1.4 Israel Rapid Acting Insulin Market Revenues & Volume, By Aspart Insulin, 2021- 2031F |
6.1.5 Israel Rapid Acting Insulin Market Revenues & Volume, By Glulisine Insulin, 2021- 2031F |
6.2 Israel Rapid Acting Insulin Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Rapid Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021- 2031F |
6.2.3 Israel Rapid Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F |
6.3 Israel Rapid Acting Insulin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Rapid Acting Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Israel Rapid Acting Insulin Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.3.4 Israel Rapid Acting Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
7 Israel Rapid Acting Insulin Market Import-Export Trade Statistics |
7.1 Israel Rapid Acting Insulin Market Export to Major Countries |
7.2 Israel Rapid Acting Insulin Market Imports from Major Countries |
8 Israel Rapid Acting Insulin Market Key Performance Indicators |
8.1 Average time to market for new rapid acting insulin products |
8.2 Number of clinical trials for innovative insulin delivery systems in Israel |
8.3 Adoption rate of rapid acting insulin compared to regular insulin in Israel |
9 Israel Rapid Acting Insulin Market - Opportunity Assessment |
9.1 Israel Rapid Acting Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Rapid Acting Insulin Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Rapid Acting Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Rapid Acting Insulin Market - Competitive Landscape |
10.1 Israel Rapid Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Israel Rapid Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here